Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
强生在分拆消费者健康部门后表示将重点放在加强业务上
On Tuesday, Johnson & Johnson (NYSE:JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost in line with estimates. First quarter results came shortly after JNJ's expansion in the cardiovascular space with the $13.1 billion acquisition of heart device firm Shockwave Medical Inc (NASDAQ:SWAV).
周二，强生公司（纽约证券交易所代码：JNJ）发布了喜忧参半的第一季度报告。由于医疗器械业务的销售额激增，调整后的收益超过了预期，而收入几乎与预期一致。第一季度业绩是在JNJ以131亿美元收购心脏设备公司Shockwave Medical Inc（纳斯达克股票代码：SWAV），扩张心血管领域后不久公布的。
First Quarter Highlights
第一季度亮点
For the period ended in March, the healthcare company posted a revenue of $21.38 billion, almost in line with LSEG's estimate of $21.4 billion. During the first three months of the year, revenue rose more than 2% YoY. JNJ...
在截至3月的期间，这家医疗保健公司公布的收入为213.8亿美元，几乎与LS...
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。